Exploring the Link: Ibritumomab Tiuxetan and Encephalitis Risk Factors
Understanding Ibritumomab Tiuxetan and Its Clinical Applications Ibritumomab Tiuxetan is a radiolabeled monoclonal antibody primarily used in the treatment of certain types of B-cell non-Hodgkin’s lymphoma. This innovative therapeutic agent combines the specificity of a monoclonal antibody with the cytotoxic effects of a radioactive isotope, yttrium-90, to target and destroy malignant cells with precision. By […]
